Omeprazole magnesium tablets, developed and produced by AstraZeneca Pharmaceutical Co., Ltd., are indicated for the treatment of duodenal ulcer, gastric ulcer and reflux esophagitis

Losec (omeprazole magnesium tablets), indicated for the treatment of duodenal ulcer, gastric ulcer and reflux esophagitis; In combination with antibiotics for the treatment of duodenal ulcers infected with Helicobacter pylori; Treatment of peptic ulcer and gastroduodenal erosion associated with non-steroidal anti-inflammatory drugs; Prevention of peptic ulcer, gastroduodenal erosion or dyspeptic symptoms caused by non-steroidal anti-inflammatory drugs; It is also used for the maintenance treatment of chronic recurrent peptic ulcer and reflux esophagitis; For the symptomatic treatment of heartburn and reflux in gastroesophageal reflux disease; Symptomatic treatment of ulcer-like symptoms and acid-related dyspepsia; It is used for the treatment of Zol-Ellison syndrome.

AstraZeneca is a global, innovation-driven biopharmaceutical company focused on developing, manufacturing and marketing prescription medicines that are making a meaningful difference in the healthcare industry. Headquartered in Shanghai, AstraZeneca China has 29 branches in major cities in Chinese mainland and one office in Hong Kong SAR. It has more than 8,000 employees nationwide. In China, AstraZeneca's business focuses on the most needed therapeutic areas for Chinese patients: cardiovascular, diabetes and metabolism, oncology and central nervous system, and digestion/respiratory/anesthesia.